Selincro
National Institutes of Health
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Nalmefene (Selincro®), an opioid receptor modulator, is approved in Japan, the European Union, and other countries for reducing…
L’alcool correspond au terme utilise pour designer l’ethanol. Si le produit est connu pour ses proprietes desinfectantes, a un…
AIMS
To characterize a contemporaneous cohort of UK general practice patients with alcohol use disorder and describe their…
Case 1 A 43-year-old man was brought by ambulance to the emergency department (ED) with severe agitation and clinical signs of…
Nalmefene (Selincro) has been recommended to help people reduce their dependence on alcohol, in final draft guidance from the…
The opioid system modulator nalmefene (Selincro®) is the first pharmacological therapy to be approved in the EU to reduce alcohol…